Copyright
©The Author(s) 2025.
World J Hepatol. May 27, 2025; 17(5): 106124
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.106124
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.106124
Figure 4 Microbiota in chronic liver disease and healthy controls: findings from abundance comparisons at phylum, family, and genus levels.
A and B: Comparison of gut microbiota (GM) abundance at the phylum level between healthy control group and chronic liver disease group. In this figure, the X-axis categorizes the sample groups, and the Y-axis shows the relative abundance of specific taxa. Different colors represent different species at the same taxonomic level. The bar chart illustrates the composition of highly expressed species within each group, facilitating the comparison of species composition and expression patterns across groups; C and D: Comparison of GM abundance at the family level between healthy control group and chronic liver disease group; E and F: Comparison of GM abundance at the genus level between healthy control group and chronic liver disease group. ZC: Healthy control group; HZ: Chronic hepatitis B group; LC: Liver cirrhosis; HCC: Hepatocellular carcinoma.
- Citation: Ma C, Yang J, Fu XN, Luo JY, Liu P, Zeng XL, Li XY, Zhang SL, Zheng S. Microbial characteristics of gut microbiome dysbiosis in patients with chronic liver disease. World J Hepatol 2025; 17(5): 106124
- URL: https://www.wjgnet.com/1948-5182/full/v17/i5/106124.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i5.106124